Skip to main content
. 2019 Nov 20;367:l6131. doi: 10.1136/bmj.l6131

Table 4.

Maternal adverse outcomes in intention to treat population. Values are numbers (percentages) unless stated otherwise

Variables Induction group (n=1381) Expectant management group (n=1379) Relative risk (95% CI) P value
Secondary maternal outcomes
Chorioamnionitis 2 (0.1) 6 (0.4) 0.33 (0.07 to 1.65) 0.29
Shoulder dystocia 6 (0.4) 4 (0.3) 1.50 (0.42 to 5.30) 0.76
Perineal tear grade 3 or 4 40 (2.9) 50 (3.6) 0.80 (0.53 to 1.20) 0.33
Postpartum haemorrhage (>1000 mL) 140 (10.1) 146 (10.6) 0.96 (0.77 to 1.19) 0.75
Wound infection 4 (0.3) 3 (0.2) 1.33 (0.30 to 5.94) 1.00
Urinary tract infection, including pyelonephritis 5 (0.4) 7 (0.5) 0.71 (0.23 to 2.24) 0.77
Endometritis 18 (1.3) 6 (0.4) 3.00 (1.19 to 7.52) 0.02
Sepsis 0 (0.0) 0 (0.0) 1.00
Exploratory maternal outcomes
Pre-eclampsia, gestational hypertension, eclampsia 19 (1.4) 42 (3.0) 0.45 (0.26 to 0.77) 0.004
Uterine rupture 0 (0.0) 0 (0.0) 1.00
Cervical tear 5 (0.4) 8 (0.6) 0.62 (0.20 to 1.90) 0.58
Venous thromboembolism 0 (0.0) 1 (0.1) 1.00
Maternal admission to intensive care unit 2 (0.1) 0 (0.0) 0.50
Maternal death 0 (0.0) 0 (0.0) 1.00